Posted on August 25, 20268/25/26
The GLP-1 Tender Signal: What 238 Awarded Bids Reveal About Who’s Really Winning
Posted on July 29, 20267/29/26
The Industry Doesn’t Have an Access Collaboration Problem. It Has an Accountability Problem.
Posted on July 10, 20267/10/26
How IRA, MFN, and HTA are rewriting oncology launch strategy
Posted on June 4, 20266/4/26
Winning in the EU JCA Era: Why Proactive Intelligence Will Define Market Access Success
Posted on May 19, 20265/19/26
Your Market Access Model is Bleeding Value
Posted on May 6, 20265/6/26
Predicting PICOs Under EU Joint Clinical Assessment: Is One Method Enough?
Posted on April 10, 20264/10/26
Stay Ahead of Change with NAVLIN Daily’s Global Policy Watch
Posted on March 17, 20263/17/26
4th Annual Brand Planning Report: Fueling Brand Plan Success Through AI‑Powered Integration
Posted on March 13, 20263/13/26
Webinar Recording | From MFPs to MFN: Navigating the New Rules of Drug Pricing in 2026
Posted on January 27, 20261/27/26